Esteban Masuda

2019

In 2019, Esteban Masuda earned a total compensation of $796.1K as Executive Vice President, Research at Rigel Pharmaceuticals, a 39% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$167,671
Option Awards$258,881
Salary$360,582
Other$8,954
Total$796,088

Masuda received $360.6K in salary, accounting for 45% of the total pay in 2019.

Masuda also received $167.7K in non-equity incentive plan, $258.9K in option awards and $9K in other compensation.

Rankings

In 2019, Esteban Masuda's compensation ranked 10,234th out of 13,971 executives tracked by ExecPay. In other words, Masuda earned more than 26.7% of executives.

ClassificationRankingPercentile
All
10,234
out of 13,971
27th
Division
Manufacturing
4,144
out of 5,701
27th
Major group
Chemicals And Allied Products
1,585
out of 2,200
28th
Industry group
Drugs
1,358
out of 1,886
28th
Industry
Pharmaceutical Preparations
1,009
out of 1,398
28th
Source: SEC filing on April 1, 2020.

Masuda's colleagues

We found six more compensation records of executives who worked with Esteban Masuda at Rigel Pharmaceuticals in 2019.

2019

Raul Rodriguez

Rigel Pharmaceuticals

Chief Executive Officer

2019

Anne-Marie Duliege

Rigel Pharmaceuticals

Chief Medical Officer

2019

Dolly Vance

Rigel Pharmaceuticals

Executive Vice President, Corporate Affairs, General

2019

Dean Schorno

Rigel Pharmaceuticals

Chief Financial Officer

2019

Eldon Mayer

Rigel Pharmaceuticals

Executive Vice President, Chief Commercial Officer

2019

Wolfgang Dummer

Rigel Pharmaceuticals

Chief Medical Officer

News

You may also like